BioCryst Pharmaceuticals ...

8.39
0.17 (2.07%)
At close: Apr 25, 2025, 3:59 PM
8.40
0.06%
After-hours: Apr 25, 2025, 05:49 PM EDT

BioCryst Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-88.88M -226.54M -247.12M -184.06M -182.81M -108.9M -101.25M -65.78M -55.14M
-10.23M 1.66M 1.44M 777K 748K 724K 770K 704K 483K
65.41M 55.62M 44.7M 34.64M 14.79M 17.72M 9.4M 12.62M 8.49M
n/a -8.05M -2.69M 1.28M -1.97M 1.9M -6.94M 2.33M 4.39M
-18.32M 106.53M 98.07M 54.2M 2.43M 1.28M 885K 876K 558K
n/a n/a n/a -55.84M 753K 464K 1.17M 1.11M -271K
n/a -32.4M -58.95M 8.12M 26.88M -872K -3.53M 9.33M -7.55M
-52.02M -95.14M -161.85M -142.16M -137.22M -89.58M -92.56M -41.14M -53.44M
n/a -2.17M -1.35M -2.38M -514K -343K -366K -328K -5.28M
n/a n/a 1.35M 2.38M 513K 366K 366K 12K 4K
-266.76M -514.41M -244.28M -10.01M -49.82M -3.02M -62.61M -107.79M -14.11M
320.48M 385.08M 117.4M 28.2M 43.48M 81.3M 67.75M 43.46M 42.65M
-1.12M 1.00 -1.35M -2.38M -513K -366K -366K -1.74M 66K
52.59M -131.5M -128.24M 15.8M -6.86M 77.93M 4.77M -66.38M 23.34M
-1.7M 58.38M 73.07M 293.87M 67.45M 19.48M 6.25M 122K 22.99M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
-4.09M -26.24M 14.77M 15.73M 141.97M 21.12M 2.85M 1.58M 317K
-5.76M 32.48M 88.03M 359.67M 302.7M 99.1M 62.5M 135.7M 23.3M
-6.12M -193.79M -201.5M 233.39M 158.63M 87.45M -25.29M 28.18M -6.79M
-52.02M -97.31M -163.2M -144.54M -137.73M -89.93M -92.93M -41.47M -58.72M